Re-licensing Study to Assess Virosomal Influenza Vaccine Formulated With WHO Recommended Influenza Strains
Clinical trial NCT01631071 · COMPLETED
Trial details
- NCT number
- NCT01631071
- Sponsor
- Crucell Holland BV
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2012-08-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.